Key Takeaways
- Export slump masked domestic strength: Standalone revenue fell 9% YoY as Europe slowed and CIS exports stopped completely, even while domestic business grew ~20%.
- Raw material tailwind lifted margins: Standalone EBITDA margin jumped 700 bps YoY to 21.2%, helped by softening input costs over two quarters, though customers clawed back 2–4% on renewals.
- Consolidated revenue hit a record: FY23 total income crossed ₹1,400 crores, up 10% YoY, with domestic sales contributing ~55% and overseas subsidiaries improving through H2.
- The capex cycle is entering its payoff window: All projects under the ₹177 crores plan finish in FY24, with management targeting 3–3.5x asset turnover and full revenue realization in 3–5 years.
- What to watch next quarter: Whether European demand actually recovers in H2 as management hopes, the pace of Sheffield Refractories integration and technology transfer to India, and progress on Visakhapatnam precast product approvals.
Revenue Breakdown: Exports vs Domestic
- Export volumes collapsed on two fronts: European steel consumption weakened under the Ukraine-Russia war, while CIS country exports shut down completely; certain Middle East markets also softened slightly. The domestic market grew ~20% but could not fully close the gap.
- Domestic steel tailwind is structural: India's steel capacity is targeted to nearly double from ~15.5-16 crore tons to ~30 crore tons by 2030–31 under the National Steel Policy, implying ~7% CAGR. Management is very confident this growth materializes.
- International demand is split: U.S. and German markets are described as very good; the U.K. is a bit slow but expected to recover. Overall overseas recovery is hoped for in the second half of this year.
Sarda: "As of today, the European market is slightly slow."
Margin Dynamics
- The raw material cycle turned favorable: Input costs softened over the last 5–6 months, driving the 700 bps standalone EBITDA margin expansion. However, rupee depreciation against the dollar partially offset the benefit.
- Price concessions were modest but real: Customers with renewed orders asked for and received 2–4% price reductions. Management frames this as a normal cycle: raw material increases lead to price hikes, decreases lead to givebacks, and margins even out over time.
- Consolidated margin guidance is 13–15%: Management expects this range to hold going forward, with standalone India margins around 15%. Overseas operations carry structurally lower EBITDA margins than India, though improvement is expected.
- Competitive margins are tight: Management notes that RHI Magnesita's margins are not very different, maybe 1–2% plus or minus.
Sarda: "Our margins will be anywhere between about 13% to 15% going forward also."
Sarda: "...this is a price game which is played between customer and us, raw material price increases, then we talk about increasing the price, if it decreases, then they talk about reducing the price. But the margins I mentioned, that 15%, is what the margin we should look at. ... Eventually, over a period of time, it evens out."
Overseas Subsidiaries
| Subsidiary | Trend | Commentary |
|---|---|---|
| Hofmann Ceramic (Germany) | ▲ Improving | Performing well with favorable margins; significant improvement over the last couple of years; running at ~80–90% utilization; creating additional capacities but has run out of space. |
| EI Ceramics (US) | ▲ Improving | Significant improvement in H2 FY23; management confident of better results in FY24; running at ~80–90% utilization with no space to expand currently. |
| Monocon (UK) | ▬ Mixed | UK market a bit slow; margins expected to improve with Sheffield Refractories acquisition. |
| Sheffield Refractories (UK) | ▶ New | Acquired 24 Feb 2023; only ~1 month in FY23 contributing ~₹20 crores top line; full-year turnover ~₹170–175 crores; profitable and expected to continue making money. |
- International ROIC is unquantified: Management acknowledged overseas EBITDA margins are lower than India's but could not provide ROIC figures when asked whether returns exceed cost of capital. The market was down during COVID but has shown good results in the last six months, with next year's figures expected to be significantly better.
Capex & Capacity Expansion
- The ₹177 crores India capex plan is nearly complete: ~₹80 crores spent through March 2023; the balance capitalizes in FY24. All planned projects finish within FY24.
- Revenue payoff is 3–3.5x investment: Brownfield expansion targets this asset turnover ratio, with full revenue realization expected in 3–5 years. The capex includes new product lines, not just existing ones.
- Capacity utilization is uneven: Hofmann and EI Ceramics run at ~80–90%; Kalunga isostatic and Side Gate at ~80–85%; other expanded products are lower at ~50%; Monocon at ~50–60%. Kandla Phase 1 was at ~80–85% before the March expansion completion.
- Kalunga land acquisition solves a bottleneck: Two land parcels (~3 acres) adjacent to the existing plant were acquired for ~₹2 crores to improve quality, debottleneck operations, and expand capacities. Qualitative improvement equipment was ordered but space was the constraint.
- Visakhapatnam precast plant is in trial stage: First product shipped in March, more in May; undergoing trials at various customers with good feedback so far. FY24 will be a product approval year with no utilization figures expected; revenue potential is 3–3.5x of the ~₹20 crores total spend once approved.
Sheffield Refractories Acquisition
- The deal was years in the making: Sheffield had been on management's radar for 5–6 years but was deferred by COVID. The company manufactures and installs monolithic refractory products specializing in blast furnace casthouse products, shotcreting material, and other specialized monolithics.
- The primary rationale is technology transfer to India: Sheffield has a highly technical product basket that IFGL does not currently make in India. Management's core thesis is bringing those products into the large and growing Indian market, enabling higher margins and synergy benefits.
- Financial details are thin: Full-year turnover is ~₹170–175 crores; the business is profitable and expected to continue making money. Management did not have capacity figures, historical EBITDA, or utilization levels available on the call.
Sarda: "...why we acquired Sheffield Refractory was primarily to take that product to other parts of the world, especially India, because those products we don't make. At Sheffield, they have a very, very good product basket in their product ranges. And we would bring those products into India. Indian market, as you know, is very big, very large and growing market. So that is where we would like to capitalize Sheffield acquisitions."
Working Capital & Balance Sheet
- Inventory and receivables have risen significantly: The increase over the past two years reflects higher average inventory holding periods post-COVID, increased realizations, and the addition of Sheffield Refractories' inventory and receivables in the March 2023 consolidated reports.
- Receivables can come down, inventory likely stays high: Management's efforts are to reduce working capital, but inventories will probably remain elevated because customers demand fast delivery and the company must be prepared to keep stock. Receivables are expected to decline.
Sarda: "...our efforts are to reduce. But I think just to handle our customers, because customers are also like asking for -- sometimes they ask for material so fast, so we have to be prepared to keep inventory. So inventories would be higher, I would say. But receivables can come down, will come down."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Capex completion | All projects under ₹177 crores India capex plan finished | Within FY24 |
| Revenue from capex | 3–3.5x asset turnover on brownfield expansion | Full realization in 3–5 years |
| Consolidated EBITDA margin | Average 13–15% going forward | Ongoing |
| R&D center operational | New research and technology center in Odisha fully operational | H1 2023 |
| Visakhapatnam precast commercialization | Product approval stage; no utilization figures expected this year | FY24 is approval year; revenue thereafter |
| European market recovery | Management hopes for improvement | H2 this year |
| EI Ceramics performance | Better results expected | FY24 |
Key Metrics
| Metric | Q4 FY23 |
|---|---|
| Consolidated total income | ₹376 cr, up 2.5% YoY, highest-ever Q4 and FY |
| Consolidated EBITDA | ₹56 cr, up 32% YoY |
| Consolidated EBITDA margin | 14.9%, up ~330 bps YoY |
| Consolidated PAT | ₹29.4 cr, up 42% YoY |
| Standalone total income | ₹217 cr, down 9% YoY |
| Standalone EBITDA | ₹46 cr, up 35% YoY |
| Standalone EBITDA margin | 21.2%, up 700 bps YoY |
| Standalone PAT | ₹23 cr, up 46% YoY |
| Domestic sales proportion | ~55% of overall sale |
| Domestic market volume growth | ~20% YoY |
| Price reduction on renewed orders | 2% to 4% |
| Overseas subsidiaries FY23 sales | ~₹595–600 cr |
| Overseas subsidiaries FY23 EBITDA | ~₹32 cr |
| Overseas subsidiaries FY23 PAT | ₹18 cr |
| Capex plan | ₹177 cr, over 50% spent or committed as of year-end, balance in FY24 |
| Capacity utilization: Hofmann and EI Ceramics | ~80–90% |
| Capacity utilization: India Kalunga isostatic and Side Gate | ~80–85% |
| Capacity utilization: Monocon | ~50–60% |
| Sheffield Refractories acquisition: annual turnover | ~GBP 1.7–1.8 cr (~₹170–175 cr), contributed ~₹20 cr in FY23 post 24 Feb acquisition |
| Final dividend recommended | ₹7 per share, 70% of face value |